Embedded Files
Bivalirudin
DMF 25531
Applicated
Eptifibatide
DMF 27651
Available
Liraglutide
DMF 29302
Icatibant Acetate
DMF 28496
Octreotide Acetate
DMF 30249
Teriparatide Acetate
DMF 32144
Ganirelix Acetate
DMF 033546
Ziconotide Acetate
DMF 33139
Linaclotide
DMF 035812
Chinese cGMP APIs
Product Name
GMP Certificate No.
Levosimendan
SC20120022
Thymosin alpha1
SC20140047
Enfuvirtide
SC20140098
Octreotide Acetate
SC20150121
Somatostatin
SC20150121
Thymopentin
SC20150121
Carbetocin
SC20160013
Atosiban
SC20170065
Research Peptide APIs for Regulatory Market
Product Name
US-DMF File Point
Stage
Degarelix
By the end of 2023
PV finished
Exenatide
By the end of 2023
PV finished
Teduglutide
Bye the end of 2024
small trial
Cetrorelix
By the end of 2023
PV finished
Semaglutide
In the middle of 2023
PV finished
Tirzepatide
In the middle of 2024
small trial finished
ReplyForward
Page updated
Google Sites
Report abuse